Learn More
Medchemexpress LLC N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide | 345627-80-7 | MFCD09833875 | 99.9% | 380.53 | C17H24N4O2S2 | 25 MG

Supplier: Medchemexpress LLC HY1000825MG
SNS-032 is a potent, ATP-competitive small-molecule inhibitor of cyclin-dependent kinases CDK9, CDK2, and CDK7. It is used in preclinical research to probe CDK-mediated control of transcription and the cell cycle and displays antitumor activity in experimental models. Reported IC50 values are 4 nM (CDK9), 38 nM (CDK2), and 62 nM (CDK7).
- Potent inhibitor of CDK9, CDK2, and CDK7.
- Low nanomolar potency supports sensitive biochemical assays.
- ATP-competitive mechanism for target-specific profiling.
- Suitable for in vitro and preclinical cellular studies.
- Available as solid and ready-to-use DMSO solution formats.
- High purity for reproducible experimental results.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.